Back to search results

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Abroad (travel likely)Recruiting

Conditions

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia · Lymphoma · Lymphoproliferative Disorder · Multiple Myeloma and Plasma Cell Neoplasm · Myelodysplastic Syndromes · Myelodysplastic/Myeloproliferative Neoplasms · Unspecified Adult Solid Tumor, Protocol Specific

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Clinical Trials Office - Barbara Ann Karmanos Cancer Institute) · 800-527-6266
    Elisabeth Heath, M.D. (Sub-investigator)
    Otto Muzik, Ph.D. (Sub-investigator)
    Mohammed N Al Hallak, M.D (Sub-investigator)
    Hirva Mamdani, M.D (Sub-investigator)
    Ammar Sukari, M.D. (Sub-investigator)
    Huailei Jiang, Ph.D. (Sub-investigator)
Study leads

  • Anthony F. Shields, MD, PhD

    Principal Investigator

    Barbara Ann Karmanos Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)